{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T08:53:06Z","timestamp":1784364786233,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T00:00:00Z","timestamp":1679184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T00:00:00Z","timestamp":1679184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018736","name":"Kaken Pharmaceutical","doi-asserted-by":"publisher","award":["19K08637"],"award-info":[{"award-number":["19K08637"]}],"id":[{"id":"10.13039\/100018736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Interstitial lung disease is frequently comorbid with dermatomyositis and has a poor prognosis, especially in patients with the anti-melanoma differentiation-associated gene 5 (MDA5) autoantibody. However, the pathogenesis of dermatomyositis-related interstitial lung disease remains unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We examined 18 and 19 patients with dermatomyositis-related interstitial lung disease and idiopathic pulmonary fibrosis (control), respectively. Lung tissues obtained from these patients were semi-quantitatively evaluated by immunohistochemical staining with in-house anti-human MDA5 monoclonal antibodies, as well as anti-human immunoglobulin (Ig) G, IgM, IgA, and complement component 3(C3) antibodies. We established human MDA5 transgenic mice and treated them with rabbit anti-human MDA5 polyclonal antibodies, and evaluated lung injury and Ig and C3 expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MDA5 was moderately or strongly expressed in the lungs of patients in both groups, with no significant differences between the groups. However, patients with dermatomyositis-related interstitial lung disease showed significantly stronger expression of C3 (p\u2009&lt;\u20090.001), IgG (p\u2009&lt;\u20090.001), and IgM (p\u2009=\u20090.001) in the lungs than control. Moreover, lung C3, but IgG, IgA, nor IgM expression was significantly stronger in MDA5 autoantibody-positive dermatomyositis-related interstitial lung disease (n\u2009=\u20099) than in MDA5 autoantibody-negative dermatomyositis-related interstitial lung disease (n\u2009=\u20099; p\u2009=\u20090.022). Treatment with anti-MDA5 antibodies induced lung injury in MDA5 transgenic mice, and strong immunoglobulin and C3 expression was observed in the lungs of the mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Strong immunoglobulin and C3 expression in the lungs involve lung injury related to dermatomyositis-related interstitial lung disease. Enhanced immune complex formation in the lungs may contribute to the poor prognosis of MDA5 autoantibody-positive dermatomyositis-related interstitial lung disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-023-02362-0","type":"journal-article","created":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T04:24:27Z","timestamp":1679199867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Enhanced immune complex formation in the lungs of patients with dermatomyositis"],"prefix":"10.1186","volume":"24","author":[{"given":"Yoshiaki","family":"Zaizen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironao","family":"Hozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriho","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,19]]},"reference":[{"key":"2362_CR1","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1002\/art.30513","volume":"63","author":"I Marie","year":"2011","unstructured":"Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum. 2011;63:3439\u201347.","journal-title":"Arthritis Rheum"},{"key":"2362_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46:626\u201336.","journal-title":"J Am Acad Dermatol"},{"key":"2362_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jbspin.2006.04.005","volume":"73","author":"C Sordet","year":"2006","unstructured":"Sordet C, Goetz J, Sibilia J. Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine. 2006;73:646\u201354.","journal-title":"Joint Bone Spine"},{"key":"2362_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11926-996-0025-3","volume":"8","author":"IN Targoff","year":"2006","unstructured":"Targoff IN. Myositis specific autoantibodies. Curr Rheumatol Rep. 2006;8:196\u2013203.","journal-title":"Curr Rheumatol Rep"},{"key":"2362_CR5","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52:1571\u20136.","journal-title":"Arthritis Rheum"},{"key":"2362_CR6","doi-asserted-by":"publisher","first-page":"26552","DOI":"10.18632\/oncotarget.15716","volume":"8","author":"L Li","year":"2017","unstructured":"Li L, Wang Q, Yang F, Wu C, Chen S, Wen X, et al. Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis. Oncotarget. 2017;8:26552\u201364.","journal-title":"Oncotarget"},{"key":"2362_CR7","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/rheumatology\/key060","volume":"57","author":"S Sato","year":"2018","unstructured":"Sato S, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Tamura M, et al. Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients. Rheumatology. 2018;57:1212\u201321.","journal-title":"Rheumatology"},{"key":"2362_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.resinv.2018.07.007","volume":"56","author":"S Sakamoto","year":"2018","unstructured":"Sakamoto S, Okamoto M, Kaieda S, Fujimoto K, Nagata S, Tominaga M, et al. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis. Respir Investig. 2018;56:464\u201372.","journal-title":"Respir Investig"},{"key":"2362_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coi.2014.12.012","volume":"32","author":"M Yoneyama","year":"2015","unstructured":"Yoneyama M, Onomoto K, Jogi M, Akaboshi T, Fujita T. Viral RNA detection by RIG-I-like receptors. Curr Opin Immunol. 2015;32:48\u201353.","journal-title":"Curr Opin Immunol"},{"key":"2362_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1126\/science.1167728","volume":"324","author":"S Nejentsev","year":"2009","unstructured":"Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science. 2009;324:387\u20139.","journal-title":"Science"},{"key":"2362_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ng.2933","volume":"46","author":"GI Rice","year":"2014","unstructured":"Rice GI, Del Toro DY, Jenkinson EM, Forte GM, Anderson BH, Ariaudo G, et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet. 2014;46:503\u20139.","journal-title":"Nat Genet"},{"key":"2362_CR12","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.468","volume":"41","author":"V Gateva","year":"2009","unstructured":"Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet. 2009;41:1228\u201333.","journal-title":"Nat Genet"},{"key":"2362_CR13","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.4049\/jimmunol.1100857","volume":"187","author":"T Robinson","year":"2011","unstructured":"Robinson T, Kariuki SN, Franek BS, Kumabe M, Kumar AA, Badaracco M, et al. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-\u03b1 and serologic autoimmunity in lupus patients. J Immunol. 2011;187:1298\u2013303.","journal-title":"J Immunol"},{"key":"2362_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/0091-6749(71)90069-8","volume":"48","author":"FJ Wenzel","year":"1971","unstructured":"Wenzel FJ, Emanuel DA, Gray RL. Immunofluorescent studies in patients with farmer\u2019s lung. J Allergy Clin Immunol. 1971;48:224\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"2362_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0091-6749(74)90115-8","volume":"53","author":"VL Moore","year":"1974","unstructured":"Moore VL, Fink JN, Barboriak JJ, Ruff LL, Schlueter DP. Immunologic events in pigeon breeders\u2019 disease. J Allergy Clin Immunol. 1974;53:319\u201328.","journal-title":"J Allergy Clin Immunol"},{"key":"2362_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1164\/rccm.201203-0513CI","volume":"186","author":"M Selman","year":"2012","unstructured":"Selman M, Pardo A, King TE Jr. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med. 2012;186:314\u201324.","journal-title":"Am J Respir Crit Care Med"},{"key":"2362_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344\u20137.","journal-title":"N Engl J Med"},{"key":"2362_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292:403\u20137.","journal-title":"N Engl J Med"},{"key":"2362_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1440-1843.2009.01687.x","volume":"15","author":"Y Kondoh","year":"2010","unstructured":"Kondoh Y, Taniguchi H, Kataoka K, Kato K, Suzuki R, Ogura T, et al. Prognostic factors in rapidly progressive interstitial pneumonia. Respirology. 2010;15:257\u201364.","journal-title":"Respirology"},{"key":"2362_CR20","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:e44\u201368.","journal-title":"Am J Respir Crit Care Med"},{"key":"2362_CR21","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","volume":"176","author":"HR Collard","year":"2007","unstructured":"Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176:636\u201343.","journal-title":"Am J Respir Crit Care Med"},{"key":"2362_CR22","first-page":"386","volume":"4","author":"SI Takenaka","year":"2015","unstructured":"Takenaka SI, Kaieda S, Kawayama T, Matsuoka M, Kaku Y, Kinoshita T, et al. IL-38: A new factor in rheumatoid arthritis. Biochem Biophys Rep. 2015;4:386\u201391.","journal-title":"Biochem Biophys Rep"},{"key":"2362_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1165\/rcmb.2003-0306OC","volume":"31","author":"Y Kitasato","year":"2004","unstructured":"Kitasato Y, Hoshino T, Okamoto M, Kato S, Koda Y, Nagata N, et al. Enhanced expression of interleukin-18 and its receptor in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 2004;31:619\u201325.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2362_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1164\/rccm.200603-316OC","volume":"176","author":"T Hoshino","year":"2007","unstructured":"Hoshino T, Kato S, Oka N, Imaoka H, Kinoshita T, Takei S, et al. Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. Am J Respir Crit Care Med. 2007;176:49\u201362.","journal-title":"Am J Respir Crit Care Med"},{"key":"2362_CR25","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.21037\/jtd.2019.09.03","volume":"11","author":"T Nouno","year":"2019","unstructured":"Nouno T, Okamoto M, Ohnishi K, Kaieda S, Tominaga M, Zaizen Y, et al. Elevation of pulmonary CD163+ and CD204+ macrophages is associated with the clinical course of idiopathic pulmonary fibrosis patients. J Thorac Dis. 2019;11:4005\u201317.","journal-title":"J Thorac Dis"},{"key":"2362_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.immuni.2013.12.014","volume":"40","author":"M Funabiki","year":"2014","unstructured":"Funabiki M, Kato H, Miyachi Y, Toki H, Motegi H, Inoue M, et al. Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity. 2014;40:199\u2013212.","journal-title":"Immunity"},{"key":"2362_CR27","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/rheumatology\/kez357","volume":"59","author":"Y Abe","year":"2020","unstructured":"Abe Y, Kusaoi M, Tada K, Yamaji K, Tamura N. Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy. Rheumatology. 2020;59:767\u201371.","journal-title":"Rheumatology"},{"key":"2362_CR28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/jca.21833","volume":"36","author":"T Saito","year":"2021","unstructured":"Saito T, Mizobuchi M, Miwa Y, Sugiyama M, Mima Y, Iida A, et al. Anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease treated with therapeutic plasma exchange: a case series. J Clin Apher. 2021;36:196\u2013205.","journal-title":"J Clin Apher"},{"key":"2362_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.transci.2007.01.004","volume":"36","author":"C Pagnoux","year":"2007","unstructured":"Pagnoux C. Plasma exchange for systemic lupus erythematosus. Transfus Apher Sci. 2007;36:187\u201393.","journal-title":"Transfus Apher Sci"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-023-02362-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T04:24:30Z","timestamp":1679199870000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-023-02362-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,19]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2362"],"URL":"https:\/\/doi.org\/10.1186\/s12931-023-02362-0","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,19]]},"assertion":[{"value":"17 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the tenets of the Declaration of Helsinki and approved by the Institutional Review Board of our institute (approval date, July 31, 2019, No. 19090). All procedures were approved by the Committee on the Ethics of Animal Experiments, Kurume University (Approval No. 2022-083, 2022-084, 2022-085). Animal care was provided in accordance with the procedures outlined in the \u201cPrinciples of laboratory animal care\u201d (National Institutes of Health Publication 86-23, revised 1985). All efforts were made to minimize the suffering of animals used in this study.\u00a0Informed consent was obtained from all the patients or the surviving family members in the form of opt-out methodology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that no potential conflicts of interest exist with any company\/organization whose products or services are discussed in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}